Inflammation-like environments limit the loss of quorum sensing in Pseudomonas aeruginosa
mSystems · 2025
DOI: 10.1128/msystems.01722-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, 2025. Verfasst von Taoran Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manc…. Hauptthemen laut MEDLINE: Quorum Sensing, Pseudomonas aeruginosa, Inflammation, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, BBSRC.
Abstract (Originalsprache)
Within-host environments are complex and multidimensional, making it challenging to link the evolutionary responses of colonizing pathogens to causal selective drivers. Loss of quorum sensing (QS) via mutation of the master regulator, lasR , is a common adaptation of Pseudomonas aeruginosa during chronic infections. Here, we use experimental evolution in host-mimicking media to show that loss of QS is constrained by environmental factors associated with host inflammation. Specifically, environments combining oxidative stress and abundant free amino acids limited loss of QS, whereas QS loss was rapid in the absence of oxidative stress, regardless of amino acids. Under oxidative stress, lasR mutations were contingent upon first decoupling regulation of oxidative stress responses from QS via mutations in the promoter region of the primary catalase, katA , or in the oxidative stress regulator, oxyR , enabling maintenance of oxidative stress tolerance. Together, our findings suggest that host inflammatory responses likely delay the loss of QS while colonizers undergo stepwise evolution, first adapting to survive lethal stressors before responding to other nutritional selective drivers that favor loss of QS. IMPORTANCE Pseudomonas aeruginosa is a common cause of chronic infections characterized by persistent inflammation. Host inflammatory responses alter within-host environments, including by increasing levels of antimicrobial stressors and releasing free amino acids through proteolysis. Here, we show stepwise adaptation of experimental P. aeruginosa populations to inflammation-like environments, first adapting to survive lethal stress by decoupling oxidative stress responses from quorum sensing (QS), before then adapting to the nutritional conditions, delaying the loss of quorum sensing. These results highlight the power of using laboratory evolution experiments to disentangle the multidimensional selective forces driving pathogen adaptation in complex within-host environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, England, United Kingdom.
- Department of Earth and Environmental Sciences, School of Natural Sciences, Faculty of Science and Engineering, The University of Manchester, Manchester, England, United Kingdom.
ORCID-Profile: Taoran Fu, Christopher G Knight, Michael A Brockhurst
Förderung
- Wellcome Trust
- BBSRC
Zitieren
APA
Fu, T., Wright, R. C. T., Gifford, D. R., Knight, C. G., & Brockhurst, M. A. (2025). Inflammation-like environments limit the loss of quorum sensing in Pseudomonas aeruginosa. mSystems. https://doi.org/10.1128/msystems.01722-24
Vancouver
Fu T, Wright RCT, Gifford DR, Knight CG, Brockhurst MA. Inflammation-like environments limit the loss of quorum sensing in Pseudomonas aeruginosa. mSystems. 2025. doi:10.1128/msystems.01722-24
BibTeX
@article{Fu2025,
author = {Fu, Taoran and Wright, Rosanna C T and Gifford, Danna R and Knight, Christopher G and Brockhurst, Michael A},
title = {Inflammation-like environments limit the loss of quorum sensing in Pseudomonas aeruginosa},
journal = {mSystems},
year = {2025},
doi = {10.1128/msystems.01722-24}
}
EUVIMED